enabling pharmaceutical companies to cure neurodegenerative diseases
The AxoSim team pride ourselves on using a collaborative process to solve problems in measurable ways, both internally and externally. We’re quality obsessed. We work tirelessly to help our pharmaceutical partners find the solutions they need to succeed, all while they learn to admire and respect our team, products, and solutions.
LOWRY CURLEY, PHD
CHIEF EXECUTIVE OFFICER
Lowry is co-founder and CEO of AxoSim. He drives the vision and implementation for product development and industry adoption of AxoSim’s Nerve-on-a-Chip®, with the goal of making a significant global impact on healthcare and medicine. Lowry received his PhD at Tulane University in biomedical engineering, focusing on tissue engineering and neuroscience. Following several postdocs, including a stint in Belgium, Lowry realized the only way to translate research breakthroughs outside of the lab was through commercialization, which drove him to return to New Orleans and begin AxoSim’s efforts.
MICHAEL MOORE, PHD
CHIEF SCIENCE OFFICER
Michael is co-founder and CSO of AxoSim and an Associate Professor of Biomedical Engineering at Tulane University, with nearly 20 years of experience in biomaterials, neuroscience, and regenerative medicine. He received his PhD from the Mayo Clinic Graduate School of Biomedical Sciences, and has experience commercializing laboratory-based technology from there as well as from his postdoc with Prof. Robert Langer at MIT. AxoSim is one of three startups to begin in Michael’s lab, though it is the only company he maintains direct involvement.
Chief Business Officer
Ben leads the commercial side of AxoSim and was a founding advisor to the company before joining full time in 2017. He is an entrepreneur and biomedical engineer. After graduating from Tulane’s biomedical engineering program, he founded Bioceptive, a women’s health company where he remains the CEO, splitting his time with AxoSim. Ben is also the Vice President-Elect of the North American 3R’s Collaborative, focused on reducing the amount of ineffective animal testing done in pharmaceutical development.
ANUP Dutt SHARMA, PHD
Anup heads AxoSim’s early product development, standardizing novel techniques to translate across the Nerve-on-a-Chip® platform. He graduated from Indian Institute of Technology Madras and worked in the tech industry before pursuing his PhD in Chemical and Biological Engineering from Iowa St. University under Dr. Surya Mallapragada and Dr. Donald Sakaguchi. Anup’s interests focus on synergistically combining engineering methods with biological processes to develop products with implications in drug testing, drug delivery, regenerative medicine, and artificial organs. Anup joined AxoSim to apply his expertise to commercial translation.
HIEU NGUYEN, PHD
Hieu leads new product R&D and validation efforts, working closely with AxoSim’s team to both design and test new applications for the Nerve-on-a-Chip®. He worked in the biotech industry before obtaining a PhD in biomedical engineering from the University of Texas at Austin, focusing on controlling Neural Cell growth using electric fields. Most recently, Hieu completed his postdoctoral training in neural electrode design and neural stimulation patterns with Dr. John Troy at Northwestern University. Hieu specializes in tissue engineering, bioengineering, and electrophysiology.
ANGELA CARTER, PHD
Angela leads AxoSim’s innovation and development 3D brain organoids used for compound screening and modeling neurological diseases. She received her PhD in Neuroscience from Baylor College of Medicine, characterizing the molecular and behavioral underpinnings of neurological disorders including epilepsy and autism spectrum disorder. Her postdoctoral training furthered her graduate work evaluating molecular hallmarks using in vitro models of severe childhood epilepsy. Angela specializes in molecular biology, synapse development, and neurological disorders.
Megan Morris, MSE
Commercialization Laboratory Manager
Megan manages our laboratory with an emphasis on commercial activities and the integration of both quality management and HSSE (health, safety, security, and environmental) management. She earned her master’s degree in Biomedical Engineering from Tulane University and comes to us with a wide range of organizational experience from various industries. She is committed to helping AxoSim ensure their commercial projects are delivered to clients with quality, integrity, and reliability.
GINA COX, MSE
CLIENT SUCCESS MANAGER
Gina manages AxoSim's client relationships, overseeing ongoing studies and developing new projects that can add value to their discovery and toxicology programs. Gina combines her technical background with her solutions-oriented attitude to deliver results for AxoSim’s partners. She received her undergraduate and master's degrees in biomedical engineering from Tulane University, after which she worked for a hyper-growth tech company where she oversaw a portfolio of clients and growing accounts.
LAURIE MCCOY, MSC
Laurie’s current efforts are working on the genetic expression of neurodegenerative diseases and image analysis. She received a master’s degree in biomedical sciences and pharmaceuticals from the University of Strathclyde in Glasgow, Scotland. Laurie is a proud native of Louisiana and a graduate of Southeastern Louisiana University.
Elizabeth’s efforts are in product R&D and leads our research in histopathology. Some of her educational highlights include coursework in Chemical and Biomolecular Engineering and studying abroad in the biotechnology industry hotbed of Copenhagen, Denmark. These experiences sparked her interest in the intersection of biotech, stem cell biology, and neurodegenerative disease. Elizabeth is thrilled to be exploring these interests with AxoSim. Long term, she plans to pursue an MD/Ph.D.
LIANA KRAMER, MS
Liana's current efforts are in product R&D and validation. Liana attended Brown University where she received a bachelors in biology and a masters in biotechnology. Prior to joining the AxoSim team, Liana received a Fulbright Award to fund research at the Utrecht University Regenerative Medicine Center in Utrecht, the Netherlands.
WESLEY ANDERSON, phd
Wesley leads the development of a 3D tissue model of pain that will be used to screen for non-addictive drugs to treat pain and opiate use disorder. He graduated from the University of Central Florida with a PhD in Biomedical Sciences, focusing on the development of an in vitro functional 3D model of the peripheral nerve. He specializes in tissue engineering and regenerative medicine as well as neuroscience.
Megan is currently focused on demyelination and neuropathy studies at AxoSim. She received an undergraduate degree in biochemical engineering from the University of Georgia, where she grew interested in tissue engineering, biomaterials, and translational research. In the future, she plans to pursue either a PhD or an MD.
TATYANA THOMPSON, BS
Tatyana attended the University of New Orleans and was awarded a degree in Biology. Her coursework focus was molecular biology and microbiology. The world of neuroscience is a bit new but she is interested in learning more about neurodegenerative diseases and the biotechnology being used to research potential cures.
Sam is currently a Senior at Tulane University pursuing a Master's Degree in Biomedical Engineering. Wearing a number of hats with AxoSim, Sam plays a role in quality assurance, administrative operations, and laboratory research. His work within multiple sides of the company has inspired an interest in startup culture and the commercialization of biotechnologies.
ACCOUNTING AND ADMINISTRATION
Jeff manages accounting and administration at AxoSim. He comes to us from the nonprofit arena where he spent many years working in project, grant, and financial management on a host of local and national efforts. Most recently he provided financial and grants management oversight for a local non-profit’s 5-year, $4 million contract under the Gulf Region Health Outreach Program, part of a four-state project to expand health care access along the Gulf Coast.
Maybe you? – We’re Hiring
Do you want to revolutionize the way that neurological drugs are developed? Join our team of solution-oriented scientists, technicians, operations people, and more – all of whom are committed to giving our partners the tools they need to deliver safer and more effective cures to patients. Make a difference while working in a vibrant startup atmosphere fueled by collaboration, innovation, and growth.
Learn more about our career opportunities!